Tonix Pharmaceuticals Holding Corp (TNXP) is a Healthcare · Biotechnology company listed on NASDAQ. Price $11.15 (-2.36%), Market cap $0.22B, 52-week low–high $12.03 ~ $61.57.
Tonix Pharmaceuticals Holding Corp., a fully integrated biopharmaceutical company, develops and commercializes therapies for central nervous system (CNS) disorders, immunology and immuno-oncology, infectious diseases, and rare diseases in the United States. The company offers TONMYA, a cyclobenzaprine HCl sublingual tablet for the treatment of fibromyalgia. It also markets Zembrace SymTouch and Tosymra for the treatment of acute migraine with or without aura in adults. In addition, the company develops TNX-102 SL, a cyclobenzaprine HCl sublingual tablet for the treatment of major depressive disorder and acute stress reaction/acute stress disorder; TNX-1300, a double-mutant cocaine esterase f
Financial statements, price targets, institutional (13F) holdings and related news for Tonix Pharmaceuticals Holding Corp are updated in real time on BlackAll Trade.
Tonix Pharmaceuticals Holding Corp trades at $11.15 (-2.36%). Real-time quotes and charts are available on BlackAll Trade.
Tonix Pharmaceuticals Holding Corp has a market cap of about $0.22B.
Tonix Pharmaceuticals Holding Corp., a fully integrated biopharmaceutical company, develops and commercializes therapies for central nervous system (CNS) disorders, immunology and immuno-oncology, inf